Novartis provides the following information on the Group's strong financial performance since its creation in 1996.

Annual results

Novartis annual results conference, including media releases and year-to-date figures.

Quarterly results

View recent and archived quarterly results.

SEC filings

Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis.

Fixed-income securities

Learn about the fixed-income securities issued by Novartis.

Product sales

View net sales data of the top 20 brands in 2024.

Expected currency impact

Expected currency impact, if mid-March exchange rates prevail in 2025.
Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Reporting and transparency hub

Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.

Learn more